Devonian Health Group (GSD.V) Q3 net loss narrowed to C$0.70 per share, from a net loss of C$1.94 per share, for the same period in 2025.
The decrease for the quarter ended April 30, is mainly related to the C$4.8 million impairment loss in the previous fiscal year, a statement said.
Devonian had C$0.7 million cash and cash equivalents as at April 30.